HUTCHMED (China) (HMDCF) Interest & Investment Income (2015 - 2021)
HUTCHMED (China)'s (HMDCF) quarterly Interest & Investment Income came in at $1.9 million in Q4 2021, up 280.28% quarter-over-quarter from $492000.0 in Q1 2021.
Analysis
HUTCHMED (China) (HMDCF) Interest & Investment Income (2015 - 2021) Analysis & Trends
HUTCHMED (China) (HMDCF) has reported Interest & Investment Income for 6 consecutive years, with $1.9 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Interest & Investment Income changed N/A year-over-year to $1.9 million in Q4 2021; TTM through Dec 2021 was $3.9 million, a N/A change from a year earlier, with the FY2025 full-year figure at $49.9 million, up 24.44% from the prior year.
- Interest & Investment Income was $1.9 million for Q4 2021 at HUTCHMED (China), up from $492000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.9 million in Q4 2021 and troughed at $196000.0 in Q1 2020.
- A 4-year average of $1.2 million and a median of $1.4 million in 2019 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income plunged 88.31% in 2020 and jumped 151.02% in 2021, its largest moves.
- Over 4 years, Interest & Investment Income stood at $1.5 million in 2018, then decreased by 9.06% to $1.4 million in 2019, then tumbled by 85.85% to $196000.0 in 2020, then jumped by 854.59% to $1.9 million in 2021.
- The last three Interest & Investment Income figures came in at $1.9 million (Q4 2021), $492000.0 (Q1 2021), and $196000.0 (Q1 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.37 Bn | 197.38 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.12 Bn | 177.94 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 132.11 Bn | 124.26 Bn | 2.84 Bn | 120.60 Mn |
| 4 | Regeneron Pharmaceuticals | 82.51 Bn | 74.52 Bn | 3.93 Bn | -48.00 Mn |
| 5 | Argenx Se | 61.69 Bn | 56.50 Bn | 1.37 Bn | 48.00 Mn |
| 6 | Moderna | 54.62 Bn | 49.48 Bn | 52.00 Mn | 67.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.14 Bn | 30.84 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.09 Bn | 30.09 Bn | 1.16 Mn | 36.92 Mn |
| 10 | HUTCHMED (China) | 376.85 Mn | 391.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 1.87 Mn |
| Mar 31, 2021 | 492,000.00 |
| Mar 31, 2020 | 196,000.00 |
| Jun 30, 2019 | 1.39 Mn |
| Mar 31, 2019 | 1.68 Mn |
| Jun 30, 2018 | 1.52 Mn |
| Mar 31, 2018 | 1.27 Mn |
| Jun 30, 2016 | 385,000.00 |
| Jun 30, 2015 | 379,000.00 |